We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

IDS LIMITED

Immunodiagnostic Systems Holdings PLC (IDS) develops, manufactures, and markets immunoassays and automated immunoanal... read more Featured Products: More products

Download Mobile App




IDS Exhibits Next Generation Automated Immunoanalyzer IDS-i10 at MEDICA 2019

By Labmedica International staff writers
Posted on 18 Nov 2019
Print article
Image: The IDS-i10 next-generation immunoanalyzer (Photo courtesy of IDS).
Image: The IDS-i10 next-generation immunoanalyzer (Photo courtesy of IDS).
Immunodiagnostic Systems {(IDS) Tyne & Wear, UK} exhibited its next generation automated immunoanalyser, the IDS-i10, at the 2019 edition of MEDICA, the world's largest trade fair for medical technology, held from 18 to 21 November in Düsseldorf, Germany. At MEDICA 2019, IDS also discussed its unique panel of automated and manual assays, with experts available onsite to answer the visitors’ queries.

More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA which drew 120,000 trade visitors from over 170 countries. In-patient and out-patient medicine, medical technology, diagnostic systems and electromedical and laboratory equipment were all on display throughout the event. The exhibition welcomed business, research and politics leaders, sharing their insights and findings with thousands of international experts. The immersive program also included a series of forums and conferences.

IDS develops, manufactures, and markets innovative immunoassays in both automated and manual formats. The company’s portfolio includes specialty testing solutions in the fields of Endocrinology, Autoimmunity, Allergy and Infectious Disease. The IDS-i10 next generation immunoanalyzer comes with faster testing capability and the capacity to connect to laboratory track systems, which can help medical professionals perform automated immunoassays more efficiently than ever. The chemiluminescence-based technology platform is entirely automated and offers continuous loading, as well as random access analysis.

Related Links:
Immunodiagnostic Systems


Print article

Channels

Copyright © 2000-2019 Globetech Media. All rights reserved.